NCT01393821View on ClinicalTrials.gov

Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 23, 2012

Primary Completion Date

May 11, 2013

Study Completion Date

July 14, 2018

Conditions
Dermatologic ComplicationsMalignant NeoplasmPain
Interventions
DRUG

menadione topical lotion

Given topically

OTHER

placebo

Given topically

OTHER

questionnaire administration

Ancillary studies

PROCEDURE

management of therapy complications

Given menadione topical lotion

Trial Locations (2)

55905

Mayo Clinic, Rochester

85054

Mayo Clinic Campus in Arizona, Phoenix

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER